Partial hepatectomy (PH) and neonatal rat short-term liver focus models were used to examine the effects of selected chemicals that had been previously tested in the National Toxicology Program (NTP) 2 9 carcinogenicity studies. C.I. Solvent Yellow 14, monuron, chlorendic acid, and 4-hydroxyacetanilide were tested for initiating and promoting activity in the PH model. Chlorendic acid, 4,4'-oxydianiline, l-amino-2.4-dibromoanthraquinone (ADBAQ), and 4-hydroxyacetanilide were similarly tested in a neonatal rat liver focus model. With the exception of 4-hydroxyacctanilide which was not carcinogenic in the NTP studies, all chemicals tested showed clear evidence of hepatocarcinogenicity. While none of the chemicals showed initiating activity in either the PH or neonatal models, promoting activity, as indicated by increased number, size, or volume fraction of histochemically detected hepatic foci of cellular alteration, was evident for all chemicals with previously demonstrated hepatocarcinogenicity. Liver tumor incidence was documented at 14 months in the PH model and at 300 days in the neonatal model. On the basis of the results obtained from these few chemicals, it is suggested that the use of short-term rat liver focus models may represent a reliable means for identifying chemicals with hepatocarcinogenic potential.
INTRODUCTION
In chemical carcinogenesis studies employing short-term and medium-term rat liver focus model systems, the histochemical identification and subsequent stereological analysis of altered hepatocellular foci (AHF) has helped establish some of the mechanistic steps involved in hepatocarcinogenesis (3, 5-8, 20, 23). In these models, the development of hepatocellular neoplasia is typically preceded by the appearance of phenotypically AHF (5-7, 9, 23, 28, 30). Despite the fact that AHF do not exhibit automonous growth (26) and that most induced AHF do not develop into liver neoplasms (1,2,7, 14, 17, 18,2 1,25,29), they are considered "preneoplastic" lesions by many investigators (1 3, 24, 28). Widespread use of such experimental models has led to the assumption that these test systems may provide a more rapid means than chronic carcinogenicity studies for assessing hepatocarcinogenic potential of chemical agents (1, 1 1, 12, 17, 27) .
Among several experimental rat liver focus model systems, 2 popular models are the partial hepatectomy (PH) model (1 9) and the neonatal model (1 5, 16) . Both have recently been improved for increased sensitivity (10, 15,22 ). The PH model involves exposure of 5-8-week-old Sprague-Dawley rats to a single "subcarcinogenic" dose of an initiator, such as diethylnitrosamine (DEN), within 24 hr afier a 2/3 PH, with subsequent repeated exposure to a tumor promoter, such as dietary phenobarbital (PB), starting 2 weeks aAer PH. The neonatal rat liver focus model involves exposure of day-old Sprague-Dawley rats to a single "subcarcinogenic" dose of initiator with subsequent repeated exposure to a dietary promoter starting at the time ofweaning. Both the PH and the neonatal models are regarded as especially sensitive to hepatocarcinogens. Use of The current study was designed to test the use of the PH and neonatal model systems to detect the initiating and promoting activity of chemical agents other than classical initiators such as DEN and classical liver tumor promoters such as PB. Test chemicals supplied by the National Toxicology Program (NTP) were used in lieu of DEN as an initiator with subsequent phenobarbital promotion or in lieu of PB as a tumor promoter following initiation with DEN. The chemicals used for this study had been previously tested in NTP 2-yr carcinogenicity studies.
ATERI RIALS AND METHODS

Test Chemicals
Monuron, chlorendic acid, C.I. Solvent Yellow 14, and 4-hydroxyacetanilide were tested in the PH model and 4,4'-oxydianiline, l-amino-2,4-dibromoanthraquinone (ADBAQ), chlorendic acid, and 4-hydroxyacetanilide were tested in the neonatal model. When tested for initiating activity, test chemicals were given as a single intraperitoneal injection in corn oil at a maximally tolerated single dose (Tables I and 11 ) determined in preliminary range-finding studies using partially hepatectomized rats (PH model studies) or neonates (neonatal model studies). Test chemicals were mixed in purified diet (TD#8 138 1, Teklad Test Diets, Madison, WI) for assessing tumor promotion activity. Preliminary and periodic chemical analyses were performed to check dose formulations and chemical stability in the corn oil and purified diet. There were no significant deviations from target concentrations of tested chemicals in any of the studies. 
1O.OOO ppm) Diethylnitrosamine Control diet
Two dietary concentrations of each test chemical were used for promotion studies (Tables I and 11 ). These concentrations were identical to concentrations used in the NTP 2-yr carcinogenicity studies (Table 111-see footnote) .
In the conduct of the liver tumor promotion studies in the partial hepatectomy and neonatal model systems, the separate investigators were permitted to conduct the studies according to standard practices used in their respective laboratories. Thus, the histochemical markers used to detect AHF and the timing of the sacrifice intervals differed in the 2 model systems. However, the same strain of rat and identical purified diet was used for all studies in each model.
PH Model Studies
Studies in the PH model were conducted at the serial frozen sections were quantitated at 6 months as previously described (4). Results are reported as total AHF and includes foci that were detected by one or more of the four phenotypic markers used. Liver tumor incidence was determined at 14 months when all gross tumor nodules were examined microscopically using hematoxylin and eosin-stained paraffin sections. Chemical identification and doses used for initiation and promotion are summarized in Table I . Numbers of rats sacrificed at 6 and 14 months are documented in Table IV . In addition to the DEN and basal diet control, several other control groups were included in these studies (data not shown).
Neonatal Model Studies
Studies in the neonatal rat liver tumor model were conducted at Argonne National Laboratory, Ar-gonne, IL. Pregnant Sprague-Dawley rats (Charles River Breeding Laboratories, Inc., Wilmington, MA) were acquired about 5 days before parturition and were housed singly in polycarbonate shoe-box cages under nearly constant temperature (70 * 2°F) and
relative humidity (50 f 10%) with a 12-hr light and 12-hr dark illumination cycle. Water and powdered diet containing 30% casein (TD#8 138 1, Teklad Test diets, Madison, WI) were available ad libitum. Within 24 hr of birth, each neonate received a single intraperitoneal injection of initiator in 0.1 ml of corn oil. At 21 days, the pups were weaned, separated by sex, and housed 3 4 per cage. They were fed test diets until sacrificed at either 75 or 300 days. Prior to sacrifice each rat received an intramuscular injection of iron dextran for the iron exclusion assay (27). AHF were detected at each sacrifice interval using the Prussian blue iron stain and by staining TOXICOUXIC PATHOLOGY for GGT and quantitated as previously described (15). Stereological results from testing the 4 chemical agents as liver tumor promoters following initiation with 4 p u g of DEN are reported as total AHF (GGT+, plus Fe-, plus GGT+ and Fe-)/ cubic cm of liver and as mean volume of AHF expressed in cubic mm. Stereological analyses were made at both 75 and 300 days. Liver tumor incidence was determined at 300 days by enumeration of gross nodules. Only representative samples were confirmed by histological examination of hematoxylin and eosin-stained paraffin sections. Chemicals and doses used for initiation and promotion are presented in Table 11 . The number of rats sacrificed at 75 days ranged from 14 to 30 per group. The number of rats sacrificed at 300 days is indicated in Number in pucnthncr is number of nu examined.
RESULTS
All test chemicals used in the present study had been previously tested in 2-yr carcinogenicity studies conducted by the National Toxicology Program. The chemicals were selected because they gave clear evidence of hepatowcinogenicity in Fischer 344 rats ( Table III) . The one exception was 4-hydroxyacetanilide which was selected as a non-hepatocarcinogenic test agent. In no instance did any of the test chemicals have any evidence of initiating activity in either the PH or the neonatal model (data not shown).
Partial Hepatectomy Model Results
The same protocol was followed for determining promoting activities of the four chemicals: C.I. Sol in volume percent of liver occupied by AHF versus the controls that were initiated with DEN and fed basal control diet (Fig. 1) . These effects were observed at the 6-month sacrifice in both sexes in high and low dose groups. The number of AHF in females was greater in the 250 ppm group than in the 500 ppm group while the volume fraction of AHF was greater in both sexes in the 500 ppm groups. The mean AHF volume was smaller in both sexes of rats There was no statistically significant increased incidence of benign or malignant hepatocellular neoplasms in rats initiated with DEN and promoted with the low or the high dose of C.I. Solvent Yellow 14 versus rats that received DEN followed by control diet (Table IV) .
Monuron. Monuron had significant (p < 0.001) promoting activity in male rats following initiation with DEN. This was evident as increases in number and volume fraction of AHF versus the control (Fig.   2 ). This effect showed an apparent dose-response. The mean focus volume of AHF was less in rats given monuron than in rats initiated with DEN and given basal control diet (data not shown). There was an increased incidence (not statistically significant) of benign hepatocellular tumors in male rats initi- ated with DEN and promoted with either the high or low dose of monuron (Table IV) .
Chlorendic acid. Chlorendic acid acted as a promoting agent producing significant (p < 0.05) increases in number of AHF and volume percent of liver occupied by AHF at the 6-month sacrifice (Fig.  3) . For both of these stereologic parameters, there was evidence of a dose response. The mean volume of AHF did not exceed that observed in the negative controls (data not shown).
Chlorendic acid promotion of DEN initiated rats resulted in an increased incidence of benign and malignant hepatocellular neoplasms after 14 months in both sexes and at both doses (Table IV) . These tumor incidences were significantly higher (p < 0.05) in most instances than those observed in DEN initiated rats that received no promotion regimen.
4-Hydro.u.vacetanilide.
There was no evidence of promoting activity in rats dosed with 4-hydroxyacetanilide following initiation with DEN with the exception of a significant (p 0.05) increase in volume fraction in low dose males. The number of A H F were significantly decreased (p < 0.001) compared to controls (Fig. 4) .
The incidence of benign hepatocellular neoplasms observed in rats that were initiated with DEN and promoted with 4-hydroxyacetanilide was less (not statistically significant) than in the controls (Table   I V) . 
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A standard protocol was followed for dctermining the promoting activity of 4.4'-oxydianiline. chlorendic acid, 1 -amino-2,4-dibromoant hraquinone (ADBAQ). and .l-hydroxyacctanilide. N o macroscopically evident liver tumors were present at 75 days. G G T and Fe were equall) efficient markers for identifying foci of cellular alteration. 
4.4'-O.u!,dianilinc.
When 4,4'-oxydianiline was tested as a promoter following neonatal initiation with DEN, there was a statistically significant (p < 0.05) increase in the number of AHF per cubic centimeter of liver in males at 75 and 300 days (Fig.  5 ) and a significant (p i 0.01) increase in number at 300 days in females (Fig. 6 ). Significant (p < 0.5) increases in mean volume of AHF were observed at 75 and 300 days in males (Fig. 8a, b ) but only at 300 days in females (p < 0.01) (Fig. 7b ). Significant increases in the incidence of macroscopic liver tumors were not evident in males or females treated for 300 days with 4,4'-oxydianiline (Table V) .
Chlorendic acid. When tested as a promoter following initiation with DEN, chlorendic acid caused a statistically significant (p < 0.0 1) increase in number of A H F per cubic cm of liver at 75 and 300 days in both doses and in both sexes (Figs. 5 and 6 ). Likewise, there was an increase (p < 0.05) in the mean size of AHF in both doses and both sexes of Table 11 ) of chemical agents. Controls (DEN) were initiated with DEN and fed basal diet. Error bars indicate standard errors and asterisks indicate statistically significant increases versus controls. The chemicals are OX = 4,4'-oxydianiline, CA = chlorendic acid, AD = 1-amino-2.4-dibromoanthraquinone (ADBAQ). and Hy = 4-h ydrox yacetanilide.
rats treated with chlorendic acid as a promoter for 75 and 300 days (Figs. 7a, b, 8a, c) . This latter effect was most pronounced in the high dose males at the 300-day sacrifice. There were no statistically significant increases in macroscopically visible liver tumors in rats that received either dose ofchlorendic acid for 300 days (Table V) .
ADBAQ. When tested as a promoter following - FIG. 8a. -Mean focus volume of foci in male rats neonatally initiated with DEN and subsequently promoted with low or high doses (see Table 11 ) of chemical agents for 75 days. Controls (DEN) were initiated with DEN and fed basal diet. Error bars indicate standard errors and asterisks indicate statistically significant increases versus controls. The chemicals are Ox = 4,4'-oxydianiline, CA = chlorendic acid. Ad = 1 -amino-2.4-dibromoanthraquinone (ADBAQ). and l i y = 4-hydroxyacetanilide. FIG. 8b. c, & d. -Mean focus volume of foci in male rats neonatally initiated with DEN and subsequently promoted with low or high doses (see Table 11 ) of chemical agents for 300 days. Controls (DEN) were initiated with DEN and fed basal diet. Error bars indicate standard errors and asterisks indicate statistically significant increases versus controls. The chemicals are 0 = 4,4'-oxydianiline, C = chlorendic acid, A = I -amino-2.4-dibromoanthraquinone (ADBAQ). and H = 4-hydroxyacetanilide. Vv -Volume fraction @I ) of liver occupied by foci. N7 -Not tested.
initiation with DEN in the neonatal model, ADBAQ caused a significant @ < 0.05) reduction in the number of AHF in females at 75 days and an increase (p < 0.0 1) in the number ofAHF in low dose females at 300 days (Fig. 6 ). An increased (p c 0.01) mean volume of AHF in rats initiated with DEN and promoted with ADBAQ was observed in low dose females at 300 days ( Fig. 7b) , in low dose males (p < 0.01) at 75 days (Fig. 8a) , and in high dose males (p < 0.01) at 300 days (Fig. 8d ). The numerically high mean focus volume in high dose females and in low dose males at 300 days was accompanied by a large standard error and was not statistically significant. There was no significant increased incidence of macroscopically evident liver tumors in rats treated with ADBAQ (Table V) . 4-Hydroxyacetanilide. When tested as a promoter following initiation with DEN, 4-hydroxyacetanilide treatment was associated with a significant (p < 0.05) decrease in number of AHF in high-dose females at 75 days and an increase in number of AHF in low-dose females at 300 days (Fig. 6) . There was an increase (p < 0.0 1) in number of AHF in high-dose males at 300 days (Fig. 5) . The size of the AHF was significantly greater in treated rats versus controls for low-and high-dose females (Fig. 7b ) and for highdose males (Fig. 8d ). There was no statistically significant increase in macroscopically visible liver tumors in rats promoted with 4-hydroxyacetanilide versus controls (Table V) .
DISCUSSION
There was no apparent AHF initiating activity for any of the chemicals tested using either the PH or the neonatal model under the present conditions. Lack of initiating activity may reflect failure to activate the test agent by the metabolically immature day-old rat used in the neonatal model or the metabolically altered regenerating liver in the PH model. It may also be that, in either model, PB does not effectively promote latent initiated cells unless the initiating agent is chemically or metabolically similar to DEN. Also, the duration of the testing regimen employed in the use of these models may be insufficient to demonstrate weak initiating activity of the chemicals tested. Additional testing would be required before categorical statements could be made about the lack of initiating activity for chemicals such as those employed in the present study.
When tested as promoters following DEN initiation, there was clear evidence of statistical increases in AHF for all but one of the chemicals known to have hepatocarcinogenic activity in 2-yr carcinogenicity studies. Because of the equivocal results obtained in the neonatal model with ADBAQ, this chemical requires retesting before more definitive conclusions are possible. It was noted that rats receiving dietary ADBAQ did not consume all of their feed, suggesting a palatability problem. Additional control groups used in the PH model included administration of the various test agents in the diet without prior initiation and resulted in no increase in AHF or tumor response versus negative controls (data not shown).
Of the 3 stereological parameters calculated for data obtained in the PH model, number of AHF/ cubic cm of liver tissue and the percent of liver occupied by AHF (volume fraction) provided clearer results than the mean focus size (mean focus volume) calculation. Since mean focus volume may be dramatically influenced by extremely large or small AHF, this calculated value is often associated with a high variability for a group of similarly treated animals. This latter point is evident in some of the neonatal model data.
Although the differential effectiveness of various phenotypic markers for AHF will be reported in detail elsewhere, it was apparent that in the PH model, PGST was the most efficient marker for AHF (data not shown). This was true for both sexes and at both doses for the 3 liver tumor-positive studies as well as for the liver tumor-negative study with 4-hydroxyacetanilide. For the neonatal rat model studies, there was no consistent differential sensitivity between GGT+, GGT+ plus Fe-, or Fe-AHF (data not shown). For the chemicals tested in the partial hepatectomy and neonatal rat liver tumor models in the present study, there was generally a clear association between positive stereological results and the known hepatocarcinogenic activity for the chemicals with the possible exception of ADBAQ (Table VI) . Because of a possible dosed feed palatability problem, it may be that neonatal rats initiated with DEN and promoted with ADBAQ did not consume a sufficient dose of the test chemical to produce an unequivocal AHF response. On the basis of these findings, it is concluded that use of either of these short-term rat liver tumor models can identify hepatocarcinogens on the basis of increases in the number of AHF detected by histochemical markers. While use of short-term rat liver focus models such as the PH and neonatal test systems appears to be a reliable means for identifying chemicals with hepatocarcinogenic potential, a broader spectrum of chemicals should be tested in these models before they are adopted as part of a standard testing regimen. Dr. Squire: How was the correlation with the H&E sections made?
Dr. Maronpot: In this study, H&E staining was not included as one of the markers, at least not in a deliberate fashion. Dr. Peraino tried to do some H&E staining on frozen sections but they were very difficult to evaluate. Some of the same compounds have been looked at in terms of H&Es in the 2-yr carcinogenicity studies in another strain of rat as Dr. Harada will present later in this symposium. It is a good question; however, I ' m sorry, I do not have any relevant data to permit an answer.
Dr. Vesselinovitch: W h y did you change the strain of rat you used if you intended to compare the results?
Dr. Maronpot: The model was originally optimized for maximum sensitivity to explore mechanisms of carcinogenesis and it was an afterthought to do a comparison. We were not trying to compare so much as to ask how this model, which does so well with DEN and phenobarbital, does with other compounds. Sprague-Dawley rats are far more sensitive than Fischer 344 rats in the model. Dr. Williams: Just a comment on the apparent difficulty you had in detecting initiating activity in these models. These are both systems in which the biotransformation capability of the liver is less than that in a mature intact animal.
